Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment
- 4 November 1996
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 11 (6), 627-632
- https://doi.org/10.1002/mds.870110606
Abstract
Experimental studies in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated monkeys have shown that akinesia and rigidity are linked to a hyperactivity of glutamatergic subthalamic nucleus neurons and that the lesion of this nucleus can ameliorate parkinsonian motor signs. In our study, high‐frequency stimulation applied at the subthalamic level was performed on two Macaca mulatta monkeys rendered hemiparkinsonian by unilateral infusion of MPTP. Its effects on rigidity and bradykinesia have been quantified. The results exhibit an important alleviation of both symptoms during the application of subthalamic stimulation comparable to that obtained during L‐Dopa treatment, but without the appearance of abnormal movements such hemiballism or dyskinesia. Our data show that subthalamic stimulation has a beneficial effect on experimental parkinsonian rigidity and bradykinesia and suggests a new therapy approach for the treatment of Parkinson's disease by using subthalamic high‐frequency stimulation instead of L‐Dopa treatment.Keywords
This publication has 20 references indexed in Scilit:
- Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated MonkeysEuropean Journal of Neuroscience, 1993
- Contralateral disappearance of parkinsonian signs after subthalamic hematomaNeurology, 1992
- RELATIONSHIP BETWEEN ELECTROMYOGRAPHIC ACTIVITY AND CLINICALLY ASSESSED RIGIDITY STUDIED AT THE WRIST JOINT IN PARKINSON'S DISEASEBrain, 1992
- Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleusThe Lancet, 1991
- Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primateMovement Disorders, 1991
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological dataBrain Research, 1990
- Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonismLife Sciences, 1990
- Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal of the Neurological Sciences, 1987
- Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus LuysiiBrain Research, 1979